[1]
Santoki, H.S., Shukla, D.M., Sood, S.V. and Malhotra, S.D. 2022. Tocilizumab induced immunosuppression in a case of adult-onset still’s disease: are these newer biologics double edged sword?. International Journal of Basic & Clinical Pharmacology. 11, 5 (Aug. 2022), 487–489. DOI:https://doi.org/10.18203/2319-2003.ijbcp20222148.